摘要
目的探讨戊酸雌二醇联合米非司酮、米索前列醇治疗稽留流产的临床疗效。方法 80例稽留流产患者,随机分为对照组(米非司酮、米索前列醇治疗)和观察组(戊酸雌二醇联合米非司酮、米索前列醇治疗),比较两组妊娠组织物排出率、宫颈扩张满意度,以及急诊清宫及人工流产综合征发生率。结果与对照组相比,观察组妊娠组织物排出率、宫颈扩张满意度均明显增高,P<0.05;与对照组相比,观察组急诊清宫率、人工流产综合征发生率均显著降低,P<0.05。结论戊酸雌二醇联合米非司酮、米索前列醇治疗稽留流产的疗效显著,不良反应少,值得临床推广。
Objective To study the clinical efficacy of estradiol valerate combined with mifepristone ,mi‐soprostol in the treatment of missed abortion .Methods The 80 patients with missed abortion were random‐ized into the control group （treatment of mifepristone and misoprostol） and the observation group （treat‐ment of estradiol valerate combined with mifepristone ,misoprostol） .The pregnancy tissue removal rate , cervical dilatation satisfaction degree ,and the incidence of emergency curettage and artificial abortion syn‐drome in two groups were compared .Results Compared with the control group ,the pregnancy tissue re‐moval rate and cervical dilatation satisfaction degree were significantly increased in the observation group （ P 〈0 .05）;compared with the control group ,the incidence of emergency curettage and artificial abortion syndrome were significantly decreased in the observation group （ P〈0 .05） .Conclusion The efficacy of es‐tradiol valerate combined with mifepristone , misoprostol is significant with less adverse reactions , and is worthy of clinical promotion .
出处
《山东医学高等专科学校学报》
2015年第4期307-309,共3页
Journal of Shandong Medical College
